1Life Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 1Life Healthcare generated cash of -$211,803,000, which is less than the previous year. Cash used in financing activities reached the amount of $61,826,000 last year. Net change in cash is therefore -$122,962,000.
Cash Flow
| 2017 | -2.71M | -4.28M | 2.73M |
|---|---|---|---|
| 2018 | -18.41M | -176.75M | 216.60M |
| 2019 | -31.67M | 23.72M | -1.37M |
| 2020 | -3.59M | -514.47M | 604.52M |
| 2021 | -88.56M | 291.80M | 27.81M |
| 2022 | -211.80M | 27.01M | 61.82M |
ONEM Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 346.05M | 115.00M | 29.32M | 38.65M | 17.22M | 21.49M |
Operating activities | ||||||
Net income | -397.84M | -254.64M | -88.71M | -52.55M | -44.41M | -30.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 91.18M | 46.49M | 22.37M | 24.50M | 9.94M | 10.68M |
Stock-based compensation expense | 146.91M | 112.29M | 35.09M | 14.87M | 13.94M | 9.53M |
| Deferred income tax benefit | 146.91M | 112.29M | 35.09M | 14.87M | 13.94M | 9.53M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -32.57M | -16.54M | -35.16M | -14.48M | -7.20M | -5.89M |
Inventories | -1.85M | 1.11M | -3.92M | 659K | 224K | -1.35M |
Accounts payable | -2.87M | 3.11M | 298K | 3.92M | 1.91M | 557K |
Cash generated by operating activities | -211.80M | -88.56M | -3.59M | -31.67M | -18.41M | -2.71M |
Investing activities | ||||||
Purchases Of Investments | -54.90M | -215.28M | -963.27M | -246.11M | -218.59M | -48.96M |
Investments In Property Plant And Equipment | -73.71M | -63.61M | -63.70M | -54.41M | -10.76M | -14.02M |
Acquisitions Net | -10.36M | -23.25M | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 27.01M | 291.80M | -514.47M | 23.72M | -176.75M | -4.28M |
Financing activities | ||||||
Common Stock Issued | 58.88M | 0 | 281.75M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -7.53M | 0 |
Repayments of term debt | 0 | -51K | -12.73M | 0 | -3.3M | 0 |
Cash used in financing activities | 61.82M | 27.81M | 604.52M | -1.37M | 216.60M | 2.73M |
Net Change In Cash | -122.96M | 231.04M | 85.67M | -9.32M | 21.43M | -4.26M |
Cash at end of period | 223.09M | 346.05M | 115.00M | 29.32M | 38.65M | 17.22M |
| Data source | Data source | Data source | Data source |